Cart
sales@molnova.com
AUTEN-99
CAS No. 904054-02-0
AUTEN-99( —— )
Catalog No. M16499 CAS No. 904054-02-0
A small molecule autophagy enhancer that inhibit the myotubularin-related phosphatase MTMR14/Jumpy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAUTEN-99
-
NoteResearch use only, not for human use.
-
Brief DescriptionA small molecule autophagy enhancer that inhibit the myotubularin-related phosphatase MTMR14/Jumpy.
-
DescriptionA small molecule autophagy enhancer that inhibit the myotubularin-related phosphatase MTMR14/Jumpy; induces autophagic flux and promotes cell survival in mammalian cell cultures; increases the number of autophagic structures in mice and Drosophila, and effectively penetrates through a blood-brain barrier model; impedes the progression of neurodegenerative symptoms in Drosophila models of Parkinson's and Huntington's diseases.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAutophagy
-
TargetAutophagy
-
RecptorAutophagy
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number904054-02-0
-
Formula Weight278.373
-
Molecular FormulaC17H14N2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name2-([1,1'-biphenyl]-4-yl)-5,6-dihydroimidazo[2,1-b]thiazole
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kovács T, et al. Sci Rep. 2017 Feb 16;7:42014.
molnova catalog
related products
-
ML-SA5
ML-SA5 is an MCOLN1 agonist and arrests autophagic flux by perturbing fusion between autophagosomes and lysosomes.
-
AGN 196996
AGN 196996 is a potent and selective inhibitor of RARα (Ki: 2 nM), exhibiting very low affinity for RARβ (Ki: 1087 nM) and RARγ (Ki: 8523 nM).
-
LYN-1604 2HCl 221675...
LYN-1604 is a novel ULK1 activator.It inducing cell death involved in ATF3, RAD21, and caspase3, accompanied by autophagy and apoptosis.?LYN-1604, to be the best candidate for a ULK1 agonist.?LYN-1604 induced cell death involved in ATF3, RAD21, and caspase3, accompanied by autophagy and apoptosis.?LYN-1604 has potential for good therapeutic effects on TNBC by targeting ULK1-modulated cell death in vivo.
